Novel CT radiomics models for the postoperative prediction of early recurrence of resectable pancreatic adenocarcinoma: A single-center retrospective study in China
- Xinze Du 1, Yongsu Ma 1, Kexin Wang 2, Xiejian Zhong 1, Jianxin Wang 1, Xiaodong Tian 1, Xiaoying Wang 2, Yinmo Yang 1
- Xinze Du 1, Yongsu Ma 1, Kexin Wang 2
- 1Department of Hepatobiliary and Pancreatic Surgery, Peking University First Hospital, Beijing, China.
- 2Department of Radiology, Peking University First Hospital, Beijing, China.
- 0Department of Hepatobiliary and Pancreatic Surgery, Peking University First Hospital, Beijing, China.
Related Experiment Videos
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Deep learning radiomics from CT scans effectively predict early recurrence in pancreatic cancer patients. This advanced approach significantly outperforms traditional methods for improved patient risk stratification.
Area Of Science
- Oncology
- Radiology
- Artificial Intelligence
Background
- Pancreatic ductal adenocarcinoma (PDAC) has a high rate of early recurrence after surgery.
- Accurate prediction of early recurrence is crucial for timely intervention and improved patient outcomes.
- Current prediction models often lack sufficient accuracy.
Purpose Of The Study
- To evaluate the predictive capability of CT-based radiomics features for early recurrence (ER) in PDAC patients.
- To compare the performance of a deep-radiomics model against clinical and conventional radiomics models.
Main Methods
- Retrospective analysis of 250 postoperative PDAC patients with preoperative CT imaging.
- Development of TNM staging, clinical, conventional radiomics, and deep-radiomics models for ER prediction (within 9 months).
- Performance evaluation using ROC-AUC, PR-AUC, DCA, NRI, and IRI.
Main Results
- The deep-radiomics model achieved the highest ROC-AUC (0.895) and PR-AUC (0.834), significantly outperforming other models.
- TNM staging showed an ROC-AUC of 0.673, clinical model 0.640, and conventional radiomics 0.722.
- Decision curve analysis and reclassification metrics confirmed the superior clinical utility of the deep-radiomics model.
Conclusions
- Deep features extracted from CT images demonstrate strong predictive performance for early recurrence in PDAC.
- The deep-radiomics model offers a significant advancement in predicting ER compared to existing methods.
- This AI-driven approach holds promise for enhancing risk stratification and guiding treatment decisions in PDAC management.
Related Experiment Videos
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.

